Evidence map›Paper›PMID 36275677›Full record

ArticleFrontiers in immunology2022

System-wide identification of myeloid markers of TB disease and HIV-induced reactivation in the macaque model of Mtb infection and Mtb/SIV co-infection.

Maya Gough, Dhiraj K Singh, Bindu Singh, Deepak Kaushal, Smriti Mehra

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maya GoughSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, United States.
Dhiraj K SinghSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, United States.
Bindu SinghSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, United States.
Deepak KaushalSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, United States.
Smriti MehraSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, United States.
Texas Biomedical Research Institute · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Viral Testing CoreU42OD010442 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Deepak Kaushal, Kathryn Shelton · 2012 to 2026
$35.6M
New England Primate Research Center Base GrantP51OD011103 · OD · HARVARD MEDICAL SCHOOL · PI FLIER, JEFFREY S · 2012 to 2013
$24.7M
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSISR01AI111914 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2015 to 2025
$11.1M
Myeloid and lymphoid immunity-specific mechanisms of IDO mediated immunosuppression and its reversal, during TBR01AI134245 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI Smriti Mehra · 2018 to 2026
$6.2M
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDSR01AI170197 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Dhiraj Kumar Singh · 2022 to 2026
$4.9M
Immune Correlates of Protection from TBR01AI134240 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KAUSHAL, DEEPAK · 2017 to 2022
$4.8M
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infectionR01AI111943 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KAUSHAL, DEEPAK, RENGARAJAN, JYOTHI · 2015 to 2019
$3.9M
Role of IDO in tryptophan pathway during Mycobacterial Tuberculosis infectionR21AI128130 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI MEHRA, SMRITI · 2017 to 2018
$449k
Correlates of protection from TB and TB/AIDS comorbidityR21AI127222 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KOUSOULAS, KONSTANTIN G · 2016 to 2017
$425k
Characterization of Protective Immunity to MTB in a Setting of HIV CoinfectionR21AI127160 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KOUSOULAS, KONSTANTIN G · 2016 to 2017
$299k
NIAID NIH HHS R01 AI111914NIAID NIH HHS R01 AI111943NIAID NIH HHS R01 AI134240NIAID NIH HHS R01 AI134245NIAID NIH HHS R01 AI170197NIAID NIH HHS R21 AI127160NIAID NIH HHS R21 AI127222NIAID NIH HHS R21 AI128130NIH HHS P51 OD011103NIH HHS P51 OD011104NIH HHS P51 OD011133NIH HHS U42 OD010442
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoinfectionHIV InfectionsInterferon Type ILatent TuberculosisLentivirus InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAdenosine TriphosphateAnimalsBiomarkersC-Reactive ProteinHumansMacacaAdenosine TriphosphateBiomarkersC-Reactive ProteinInterferon Type Iactive TBlatent TBmacrophagemyeloidnonhuman primatereactivationSIVtuberculosis

Identifiers

PMID36275677
PMCPMC9583676
OpenAlexW4301586638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.